top of page

Neurocognitive Decline

Neurocognitive Decline encompasses many diseases including dementia, Parkinson's disease and Alzheimer's. Although there have been some advances with different pharmaceutical products, these have by and large not impacted disease progression. However, there are promising results from non-standard of care therapy that have been researched.

Alzheimer's disease

Alzheimer's disease and type 2 diabetes has been theorized to be connected via a metabolic syndrome with impaired insulin signaling and insulin resistance, enough that some have called Alzheimer's "diabetes of the brain" or "type 3 diabetes".

The information provided on this website is for educational and research purposes only, and does not substitute for professional medical advice. You should consult your physician or health care professional to determine if any of the information is right for your unique needs.

©2024 by Hippocrates Research Foundation. Proudly created with Wix.com

bottom of page